Literature DB >> 22849968

Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England.

M A Balogun1, J V Parry, K Mutton, C Okolo, L Benons, H Baxendale, T Hardiman, E H Boxall, J Sira, M Brown, S Barnett, U Gungabissoon, A Williams, D A Kelly, S Vijeratnam, S Ijaz, B Taylor, C G Teo, M E Ramsay.   

Abstract

The aim of this study was to estimate the amount of childhood hepatitis B virus transmission in children born in the UK, a very low-prevalence country, that is preventable only by universal hepatitis B immunization of infants. Oral fluid specimens were collected from schoolchildren aged 7-11 years in four inner city multi-ethnic areas and tested for the presence of antibody to hepatitis B core antigen (anti-HBc). Those found positive or indeterminate were followed up with testing on serum to confirm their hepatitis B status. The overall prevalence of anti-HBc in children was low [0.26%, 95% confidence interval (CI) 0.14-0.44]. The estimated average annual incidence of hepatitis B was estimated to be 29.26/100 000 children (95% CI 16.00-49.08). The total incidence that is preventable only by a universal infant immunization programme in the UK was estimated to be between 5.00 and 12.49/100 000. The study demonstrates that the extent of horizontal childhood hepatitis B virus transmission is low in children born in the UK and suggests that schools in the UK are an uncommon setting for the transmission of the virus. Targeted hepatitis B testing and immunization of migrants from intermediate- and high-prevalence countries is likely to be a more effective measure to reduce childhood transmission than a universal infant immunization programme.

Entities:  

Mesh:

Year:  2012        PMID: 22849968      PMCID: PMC9151864          DOI: 10.1017/S0950268812001513

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  49 in total

Review 1.  Novel methods for the detection of microbial antibodies in oral fluid.

Authors:  Anne McKie; Andrew Vyse; Christopher Maple
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006.

Authors:  Isabelle Giraudon; Nadia Permalloo; Grainne Nixon; Andre Charlett; Sandra Cohuet; Sema Mandal; Mary Ramsay; Bharat C Patel; Helen Maguire
Journal:  Vaccine       Date:  2009-01-09       Impact factor: 3.641

3.  Developed countries could pay for hepatitis B vaccination in developing countries.

Authors:  N J Gay; W J Edmunds
Journal:  BMJ       Date:  1998-05-09

4.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

5.  Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy.

Authors:  S Hahné; M Ramsay; K Soldan; K Balogun; P Mortimer
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

Review 6.  Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.

Authors:  Susan Hahné; Mary Ramsay; Koye Balogun; W John Edmunds; Philip Mortimer
Journal:  J Clin Virol       Date:  2004-04       Impact factor: 3.168

Review 7.  Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study.

Authors:  Ruggero Montesano
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

8.  Hepatitis B carriers in Sweden--effects of immigration.

Authors:  M Lindh; G Norkrans; K Stenqvist; K Eriksson; J Taranger
Journal:  Scand J Infect Dis       Date:  1993

9.  Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.

Authors:  F J Mahoney; M Lawrence; C Scott; Q Le; S Lambert; T A Farley
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

10.  Control of hepatitis B in the United Kingdom.

Authors:  M Ramsay; N Gay; K Balogun; M Collins
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

View more
  2 in total

Review 1.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

Review 2.  Saliva and viral infections.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  Periodontol 2000       Date:  2016-02       Impact factor: 7.589

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.